Dauren Ayaganov

Dr. Dauren Ayaganov

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2023 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Open access
DADauren Ayaganov
Dauren Ayaganov
AKAidyn Kuanyshbek
Aidyn Kuanyshbek
IVIvan Vakhrushev
Ivan Vakhrushev
TLTatyana Li
Tatyana Li
Cardiac surgery with cardiopulmonary bypass (CPB) is associated with hypofibrinogenemia and severe bleeding requiring transfusion. Guidelines recommend cryoprecipitate or fibrinogen concentrate (FC) for the treatment of acquired hypofibrinogenemia. This study compared cryoprecipitate and FC for the correction of acquired hypofibrinogenemia and the associated costs. A single-center, prospective, randomized study evaluating patients with hypofibrinogenemia after cardiac surgery. The primary endpoint was direct treatment cost. Secondary endpoints included the change in fibrinogen level after FC and/or cryoprecipitate dosing. A single-center study in Astana, Kazakhstan. Participants who underwent CPB from 2021 to 2022 and developed clinically significant bleeding and hypofibrinogenemia. Patients were randomized to receive cryoprecipitate or FC. Eighty-eight adult patients with acquired hypofibrinogenemia (<2.0 g/L) after CPB were randomized to receive cryoprecipitate (N = 40) or FC (N = 48), with similar demographics between groups. Overall, mean ± SD 9.33 ± 0.94 units (range, 8-10) cryoprecipitate or 1.40 ± 0.49 g (1-2) FC was administered to the 2 groups. From before administration to 24 hours after, mean plasma fibrinogen increased by a mean ± SD of 125 ± 65 and 96 ± 65 mg/dL in the cryoprecipitate and FC groups, respectively. At 48 hours after administration, there was no significant difference in fibrinogen levels between groups. The mean direct cost of treatment with FC was significantly lower than with cryoprecipitate (p < 0.0001): $1,505.06 ± $152.40 and $631.75 ± $223.67 per patient for cryoprecipitate and FC, respectively. Analysis of plasma fibrinogen concentration showed that cryoprecipitate and FC had comparable effectiveness. However, FC is advantageous over cryoprecipitate due to its ease of handling, lower cost, and high purity.

19 November 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TLTatyana Li
Tatyana Li
Azhar ZhailauovaAzhar Zhailauova
Azhar Zhailauova
IWIwan Wachruschew
Iwan Wachruschew
AKAidyn Kuanyshbek
Aidyn Kuanyshbek
STShaimurat Tulegenov
Shaimurat Tulegenov
Theodoros AslanidisTheodoros Aslanidis
Theodoros Aslanidis
Background: Discontinuing mechanical ventilation during cardiopulmonary bypass (CPB) is common but may adversely affect postoperative pulmonary function. This study aimed to evaluate the impact of stopping ventilation during CPB on postoperative gas exchange, radiographic findings, intensive care unit (ICU) length of stay (LOS), mortality, reintubation, re-exploration, and bleeding. Methods: A prospective observational study was performed involving adult patients scheduled for elective cardiac surgery requiring CPB. Participants were divided into ventilated and non-ventilated groups according to intraoperative strategy. Postoperative arterial carbon dioxide levels (PaCO2), arterial partial pressure of oxygen (PaO2), the PaO2/FiO2 ratio (P/F ratio), arterial oxygen saturation (SaO2), and the ratio of PaCO2 to minute ventilation (PaCO2/MV) were measured before the induction of anesthesia (within 5 min after transportation into the operating room), postoperatively within 5–10 min after transportation to the ICU, and in a 24 h postoperative period. Chest X-ray data, mechanical ventilation time, LOS in ICU, re-exploration, reintubation, and bleeding parameters were documented. Analyses were also conducted with the estimation of the age effect and BMI. Results: Individuals in the non-ventilated group exhibited lower postoperative P/F ratios and elevated postoperative PaCO2 and PaCO2/MV ratios. The difference in gas exchange leveled off within 24 h. There was no difference in the incidence of atelectasis (postoperatively in a 24 h period), mechanical ventilation time, LOS in ICU, or mortality. However, the incidence of bleeding was higher in the non-ventilated group (χ2 = 5.78, p = 0.016). Interestingly, postoperative PaCO2 and PaCO2/MV peaked in the 50-year age group. Conclusions: Continued mechanical ventilation during CPB correlates with better postoperative gas exchange, better CO2 clearance, and fewer bleeding events. The results suggest that maintaining low tidal volume ventilation during CPB may provide benefits, especially for patients aged 50 years.

15 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
TLTatyana Li
Tatyana Li
Azhar ZhailauovaAzhar Zhailauova
Azhar Zhailauova
IWIwan Wachruschew
Iwan Wachruschew
AKAidyn Kuanyshbek
Aidyn Kuanyshbek
STShaimurat Tulegenov
Shaimurat Tulegenov
Theodoros AslanidisTheodoros Aslanidis
Theodoros Aslanidis
Background: The practice of discontinuing mechanical ventilation during cardiopulmonary bypass (CPB) has been widely adopted in various cardiac surgery centers. Nonetheless, concerns have emerged regarding its possible adverse effects on postoperative pulmonary function. This study aimed to evaluate the effects of discontinued mechanical ventilation during CPB on postoperative gas exchange, X-ray results, ICU stay, mortality, reintubation, re-exploration, and bleeding. Methods: A prospective observational study was performed involving adult patients scheduled for elective cardiac surgery requiring CPB. Participants were divided into two groups according to their intraoperative ventilation strategy: one group had ventilation halted for a period required to perform surgical intervention (non-ventilated group), while the other maintained it (ventilated group) throughout CPB. Postoperative arterial carbon dioxide levels (PaCO2), arterial partial pressure of oxygen (PaO2), PaO2/FiO2 ratio (P/F ratio), arterial oxygen saturation (SaO2), and the ratio of PaCO2 to minute ventilation (PaCO2/MV) were measured at induction, postoperatively (in the ICU), and in a 24 h postoperative period. Chest X-ray data, mechanical ventilation time, LOS in ICU, re-exploration, reintubation, and bleeding parameters were documented. Analyses were also conducted across seven distinct age categories: 80 years. Results: Individuals in the non-ventilated group exhibited elevated postoperative PaCO2 and PaCO2/MV ratios and lower postoperative P/F ratios. The difference in gas exchange leveled off within 24 h. There was no difference in the incidence of atelectasis (postoperatively in a 24 h period), in mechanical ventilation time, LOS in ICU, or mortality. Interestingly, postoperative PaCO2/MV peaked in the 40–50-year age group. Conclusions: Continued mechanical ventilation during CPB correlates with better postoperative gas exchange and better CO2 clearance. These results imply that maintaining low tidal volume ventilation during CPB may provide benefits, especially for patients aged 40–60 years.